Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimephosphon in Acute Ischemic Stroke
NCT07167550Phase 3Recruiting
- Sponsor
- Tatkhimpharmpreparaty
- Start
- Sep 2025
- Primary completion
- Jan 2026
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimephosphon in ischemic stroke, sponsored by Tatkhimpharmpreparaty. Started Sep 2025; status: recruiting.
02
Drugs
dimephosphon
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07167550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07167550.